John A. Printen

1.5k total citations
18 papers, 1.2k citations indexed

About

John A. Printen is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, John A. Printen has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in John A. Printen's work include Metabolism, Diabetes, and Cancer (5 papers), Fungal and yeast genetics research (4 papers) and Fungal Biology and Applications (3 papers). John A. Printen is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Fungal and yeast genetics research (4 papers) and Fungal Biology and Applications (3 papers). John A. Printen collaborates with scholars based in United States, United Kingdom and Brazil. John A. Printen's co-authors include Alan R. Saltiel, G. F. Sprague, Matthew Brady, Vered Ribon, Brian K. Kay, Noah G. Hoffman, Cynthia Corley Mastick, Ahmir H. Khan, Jeffrey E. Pessin and Sean M. Crosson and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

John A. Printen

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Printen United States 12 926 194 171 151 137 18 1.2k
Daniel L. Friedman United States 22 1.0k 1.1× 214 1.1× 147 0.9× 108 0.7× 133 1.0× 34 1.6k
Xin Gu United States 21 1.5k 1.6× 273 1.4× 208 1.2× 228 1.5× 65 0.5× 34 2.1k
Yukihito Kabuyama Japan 23 1.2k 1.3× 296 1.5× 72 0.4× 148 1.0× 54 0.4× 40 1.8k
Amy K. Walker United States 19 1.1k 1.1× 121 0.6× 133 0.8× 202 1.3× 59 0.4× 29 1.6k
Jung Hwan Kim United States 19 780 0.8× 318 1.6× 82 0.5× 154 1.0× 41 0.3× 31 1.1k
Kendall J. Condon United States 9 1.2k 1.3× 274 1.4× 99 0.6× 165 1.1× 32 0.2× 11 1.7k
Jose M. Orozco United States 7 965 1.0× 269 1.4× 111 0.6× 163 1.1× 34 0.2× 8 1.3k
Virginia Fonte United States 12 642 0.7× 221 1.1× 50 0.3× 307 2.0× 63 0.5× 14 1.1k
Louise Gerber United States 25 1.2k 1.3× 294 1.5× 82 0.5× 202 1.3× 62 0.5× 31 1.8k
Susan Zollman United States 19 1.1k 1.2× 139 0.7× 232 1.4× 123 0.8× 44 0.3× 21 1.9k

Countries citing papers authored by John A. Printen

Since Specialization
Citations

This map shows the geographic impact of John A. Printen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Printen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Printen more than expected).

Fields of papers citing papers by John A. Printen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Printen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Printen. The network helps show where John A. Printen may publish in the future.

Co-authorship network of co-authors of John A. Printen

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Printen. A scholar is included among the top collaborators of John A. Printen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Printen. John A. Printen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shukla, Sunita J., Ðắc-Trung Nguyễn, Ryan MacArthur, et al.. (2009). Identification of Pregnane X Receptor Ligands Using Time-Resolved Fluorescence Resonance Energy Transfer and Quantitative High-Throughput Screening. Assay and Drug Development Technologies. 7(2). 143–169. 45 indexed citations
2.
Johnson, Ronald L., Ruili Huang, Ajit Jadhav, et al.. (2009). A quantitative high-throughput screen for modulators of IL-6signaling: a model for interrogating biological networks using chemical libraries. Molecular BioSystems. 5(9). 1039–1050. 11 indexed citations
3.
Xia, Menghang, Kun Bi, Ruili Huang, et al.. (2009). Identification of small molecule compounds that inhibit the HIF-1 signaling pathway. Molecular Cancer. 8(1). 117–117. 27 indexed citations
4.
Singh, J. J., Michael Salcius, Bart L. Staker, et al.. (2008). DcpS as a Therapeutic Target for Spinal Muscular Atrophy. ACS Chemical Biology. 3(11). 711–722. 100 indexed citations
5.
Crosson, Sean M., Ahmir H. Khan, John A. Printen, Jeffrey E. Pessin, & Alan R. Saltiel. (2003). PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. Journal of Clinical Investigation. 111(9). 1423–1432. 90 indexed citations
6.
Crosson, Sean M., Ahmir H. Khan, John A. Printen, Jeffrey E. Pessin, & Alan R. Saltiel. (2003). PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. Journal of Clinical Investigation. 111(9). 1423–1432. 7 indexed citations
7.
Delaney, Amy M., John A. Printen, Huifen Chen, Eric B. Fauman, & David T. Dudley. (2002). Identification of a Novel Mitogen-Activated Protein Kinase Kinase Activation Domain Recognized by the Inhibitor PD 184352. Molecular and Cellular Biology. 22(21). 7593–7602. 59 indexed citations
8.
Printen, John A., et al.. (2002). Assay for Intracellular Calcium Using a Codon-Optimized Aequorin. BioTechniques. 33(4). 730–734. 22 indexed citations
9.
Bellosta, Stefano, Franco Bernini, Giulia Chinetti, et al.. (2002). Macrophage function and stability of the atherosclerotic plaque: progress report of a European project.. PubMed. 12(1). 3–11. 9 indexed citations
10.
Mastick, Cynthia Corley, Matthew Brady, John A. Printen, Vered Ribon, & Alan R. Saltiel. (1998). Spatial determinants of specificity in insulin action. Molecular and Cellular Biochemistry. 182(1-2). 65–71. 15 indexed citations
11.
Ribon, Vered, John A. Printen, Noah G. Hoffman, Brian K. Kay, & Alan R. Saltiel. (1998). A Novel, Multifunctional c-Cbl Binding Protein in Insulin Receptor Signaling in 3T3-L1 Adipocytes. Molecular and Cellular Biology. 18(2). 872–879. 176 indexed citations
12.
Brady, Matthew, John A. Printen, Cynthia Corley Mastick, & Alan R. Saltiel. (1997). Role of Protein Targeting to Glycogen (PTG) in the Regulation of Protein Phosphatase-1 Activity. Journal of Biological Chemistry. 272(32). 20198–20204. 67 indexed citations
13.
Printen, John A., Matthew Brady, & Alan R. Saltiel. (1997). PTG, a Protein Phosphatase 1-Binding Protein with a Role in Glycogen Metabolism. Science. 275(5305). 1475–1478. 247 indexed citations
14.
Yashar, Beverly M., Kenji Irie, John A. Printen, et al.. (1995). Yeast MEK-Dependent Signal Transduction: Response Thresholds and Parameters Affecting Fidelity. Molecular and Cellular Biology. 15(12). 6545–6553. 61 indexed citations
15.
Printen, John A. & G. F. Sprague. (1994). Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade.. Genetics. 138(3). 609–619. 276 indexed citations
16.
Ferguson, Betsy, et al.. (1994). The yeast pheromone response pathway: new insights into signal transmission.. PubMed. 40(3). 223–8. 8 indexed citations
17.
Printen, John A., Susan L. Woodard, James R. Herman, Deborah A. Roess, & B. George Barisas. (1993). Membrane changes in lipopolysaccharide-stimulated murine B lymphocytes associated with cell activation. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1148(1). 91–96.
18.
Printen, John A., et al.. (1991). Corticosteroid effects on lipid lateral diffusion in CEM-C1 and CEM-C7 acute lymphoblastic leukemia cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1094(1). 134–137. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026